- Home
- GNFT vs OM Comparison
GNFT vs OM Comparison
Compare GNFT & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- OM
- Stock Information
- Founded
- GNFT 1999
- OM 2003
- Country
- GNFT France
- OM United States
- Employees
- GNFT N/A
- OM N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GNFT Health Care
- OM Health Care
- Exchange
- GNFT Nasdaq
- OM Nasdaq
- Market Cap
- GNFT 216.7M
- OM 233.1M
- IPO Year
- GNFT 2019
- OM 2020
- Fundamental
- Price
- GNFT $4.24
- OM $4.67
- Analyst Decision
- GNFT Strong Buy
- OM Strong Buy
- Analyst Count
- GNFT 2
- OM 3
- Target Price
- GNFT $10.00
- OM $16.00
- AVG Volume (30 Days)
- GNFT 9.4K
- OM 618.9K
- Earning Date
- GNFT 09-22-2025
- OM 11-10-2025
- Dividend Yield
- GNFT N/A
- OM N/A
- EPS Growth
- GNFT N/A
- OM N/A
- EPS
- GNFT N/A
- OM N/A
- Revenue
- GNFT $52,994,715.00
- OM $120,069,000.00
- Revenue This Year
- GNFT $3.14
- OM $12.46
- Revenue Next Year
- GNFT N/A
- OM $10.51
- P/E Ratio
- GNFT N/A
- OM N/A
- Revenue Growth
- GNFT N/A
- OM 4.65
- 52 Week Low
- GNFT $2.55
- OM $4.53
- 52 Week High
- GNFT $4.79
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- GNFT 54.62
- OM 15.45
- Support Level
- GNFT $4.10
- OM $11.41
- Resistance Level
- GNFT $4.38
- OM $12.47
- Average True Range (ATR)
- GNFT 0.19
- OM 0.82
- MACD
- GNFT 0.02
- OM -0.97
- Stochastic Oscillator
- GNFT 82.31
- OM 1.41
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.